BIOACTIVATION OF -2,4-DI-1-PYRROLIDINYL-7H-PYRROLO[2,3-D]PYRIMIDINE (U-89843) TO REACTIVE INTERMEDIATES THAT BIND COVALENTLY TO MACROMOLECULES AND PRODUCE GENOTOXICITY
Zy. Zhao et al., BIOACTIVATION OF -2,4-DI-1-PYRROLIDINYL-7H-PYRROLO[2,3-D]PYRIMIDINE (U-89843) TO REACTIVE INTERMEDIATES THAT BIND COVALENTLY TO MACROMOLECULES AND PRODUCE GENOTOXICITY, Chemical research in toxicology, 9(8), 1996, pp. 1230-1239
U-89843 is a novel pyrrolo[2,3-d]pyrimidine antioxidant with prophylac
tic activity in animal models of lung inflammation. During preclinical
safety evaluation, U-89843 was found to give a positive response in t
he in vitro unscheduled DNA synthesis (UDS) assay, an assay which meas
ures DNA repair following chemically-induced DNA damage in metabolical
ly competent rat hepatocytes. Incubation of [C-14]U-89843 with liver m
icrosomes resulted in covalent binding of radioactive material to macr
omolecules by a process that was NADPH-dependent. U-89843 has been sho
wn to undergo C-Ci methylhydroxylation to give U-97924, in rat both in
vivo and in vitro, in a reaction catalyzed by cytochrome P450 2C11. S
ynthetical U-97924 is chemically reactive and undergoes dimerization i
n aqueous solution. The dimerization of U-97924 was significantly inhi
bited by addition of nucleophiles such as-methanol, glutathione, and N
-acetylcysteine. Characterization of the corresponding methanal glutat
hione, and N-acetylcysteine adducts of U-97924 supported the hypothesi
s of a reaction pathway involving re active iminium species formed via
dehydration of U-97924. The metabolism-dependent irreversible covalen
t binding of radioactive material to liver microsomal protein and DNA
also is dramatically reduced in the presence of reduced reduced glutat
hione (GSH). A trifluoromethyl analog of U-89843 was prepared in-an ef
fort to block the corresponding metabolic hydroxylation pathway. This
new compound (U-107634) was found to be negative in the ill vitro UDS
assay, and its metabolic susceptibility toward hydroxylation at the C-
6 methyl group was eliminated. These observations suggest that the pos
itive in vitro UDS results of U-89843 are mediated by the bioactivatio
n of U-89843, leading to reactive electrophilic intermediates derived
from the (hydroxymethyl)pyrrole metabolite U-97924.